Zanamivir contraindications

Revision as of 23:47, 2 January 2014 by Gerald Chi (talk | contribs)
Jump to navigation Jump to search
Zanamivir
RELENZA® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
Directions for Use
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Contraindications

Do not use in patients with history of allergic reaction to any ingredient of RELENZA including milk proteins [see Warnings and Precautions (5.2), Description (11)].[1]


References

  1. "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021036s019lbl.pdf" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.